Pentabase Receives $339K from Angel Investor | GenomeWeb
NEW YORK (GenomeWeb News) – Odense, Denmark-based PentaBase has received DKK 2 million (US$339,000) from an unnamed angel investor, the firm said this week.
 
PentaBase, which is developing molecular diagnostics and sells real-time PCR-based probes, said that the funding will be used to increase sales of its platform technologies, services, and diagnostic tests for infectious diseases. The firm also offers DNA sequencing services.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.